Market closed

InspireMD/$NSPR

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About InspireMD

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Ticker

$NSPR
Trading on

Industry

Health Care Equipment & Supplies

Headquarters

Tel Aviv, Israel

Employees

80

InspireMD Metrics

BasicAdvanced
$78M
Market cap
-
P/E ratio
-$0.74
EPS
0.98
Beta
-
Dividend rate
$78M
0.98
$3.42
$1.81
68K
6.386
5.874
1.649
1.649
-37.24%
-66.75%
16.698
1.87
1.87
-5.529
24.70%
-31.36%
27.73%
-32.62%

What the Analysts think about InspireMD

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for InspireMD stock.

InspireMD Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

InspireMD Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NSPR

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for InspireMD stock?

InspireMD (NSPR) has a market cap of $78M as of December 24, 2024.

What is the P/E ratio for InspireMD stock?

The price to earnings (P/E) ratio for InspireMD (NSPR) stock is 0 as of December 24, 2024.

Does InspireMD stock pay dividends?

No, InspireMD (NSPR) stock does not pay dividends to its shareholders as of December 24, 2024.

When is the next InspireMD dividend payment date?

InspireMD (NSPR) stock does not pay dividends to its shareholders.

What is the beta indicator for InspireMD?

InspireMD (NSPR) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.